CX 2024 Programme
Day 3 Afternoon: Abdominal Aortic Aneurysm Controversies - Thursday, 25th April
Venue: Theatre 1
Time: 13:00 - 18:00
Abdominal Aortic Aneurysm Controversies
Time: 13:30 - 15:20
| Anchor: | Tilo Koelbel, Hamburg, Germany |
| Moderators: | Janet Powell, London, United Kingdom |
| Andrea Kahlberg, Milan, Italy |
13:30 - 13:40
What is new on the 2024 AAA guidelines
| Speaker: | Isabelle Van Herzeele, Ghent, Belgium |
13:40 - 13:45
Audience participation & discussion
13:45 - 13:55
Sarcopenia and outcomes of AAA intervention
| Speaker: | Alun Davies, London, United Kingdom |
13:55 - 14:00
Audience participation & discussion
14:00 - 14:05
Mid-term outcomes of a conformable EVAR device in challenging aortic necks
| Speaker: | Jean Paul de Vries, Groningen, Netherlands |
14:05 - 14:10
Audience participation & discussion
14:10 - 14:20
Edited Case: Transformative treatment for small to medium-sized AAA: Pre-clinical data and technique
| Speaker: | Ramon Varcoe, Sydney, Australia |
14:20 - 14:25
Audience participation & discussion
14:25 - 14:30
Growth stabilising therapy for small to medium-sized AAA: Clinical data from a first-in-human study
| Speaker: | Andrew Holden, Auckland, New Zealand |
14:30 - 14:40
Audience participation & discussion
14:40 - 14:45
Update on a novel abdominal aortic stent graft system and sac regression
| Speaker: | Michael Stoner, Rochester, United States |
14:45 - 14:50
Audience participation & discussion
14:50 - 15:10
Great Debate: Volume-outcome relationship of AAA repair calls for a combined recommendation of EVAR and OAR hospital volumes
For the motion
14:50 - 14:55
| Ian Loftus, London, United Kingdom |
15:00 - 15:05
| Kevin Mani, Uppsala, Sweden |
Against the motion
14:55 - 15:00
| David Stone, Hanover, United States |
15:05 - 15:10
| Maarit Venermo, Helsinki, Finland |
15:10 - 15:20
Audience participation, discussion & voting
Sponsored Education
Time: 15:20 - 15:50
Tea break
Time: 15:50 - 16:10
Abdominal Aortic Aneurysm Controversies (Continued)
Time: 16:10 - 17:15
| Anchor: | Janet Powell, London, United Kingdom |
| Moderators: | Sean Lyden, Cleveland, United States |
| Carla Van Rijswijk, Leiden, Netherlands |
16:10 - 16:15
Podium First: Post-market experience with an abdominal stent graft system: JAGUAR trial Update
| Speaker: | Sean Lyden, Cleveland, United States |
16:15 - 16:20
Audience participation & discussion
16:20 - 16:30
Core outcomes, cognitive function and secondary rupture risk after AAA repair
| Speaker: | Janet Powell, London, United Kingdom |
16:30 - 16:35
Audience participation & discussion
16:35 - 16:40
Podium First: Long-term outcomes of the ICEBERG study
| Speaker: | Michel Reijnen, Arnhem, Netherlands |
16:40 - 16:45
Audience participation & discussion
16:45 - 16:50
Edited Case: EVAR with an ultra-low-profile device in challenging cases
| Speaker: | Michele Antonello, Padua, Italy |
16:50 - 16:55
Audience participation & discussion
16:55 - 17:05
Debate: New polymer-based aneurysm sac management is the future and differs from previously failed polymer-based technologies
For the motion
16:55 - 17:00
| Andrew Holden, Auckland, New Zealand |
Against the motion
17:00 - 17:05
| Giovanni Pratesi, Roma, Italy |
17:05 - 17:15
Audience participation & discussion
Endovascular Aneurysm Repair Follow Up
Time: 17:15 - 18:00
| Anchor: | Alexander Zimmermann, Zurich, Switzerland |
| Moderators: | Sean Lyden, Cleveland, United States |
| Carla Van Rijswijk, Leiden, Netherlands |
17:15 - 17:25
Time patterns of reinterventions during FU in the UK Compass Trial
| Speaker: | Rao Vallabhaneni, Liverpool, United Kingdom |
17:25 - 17:30
Audience participation & discussion
17:30 - 17:40
Survey on diagnosis, management and prevention of type II endoleak
| Speaker: | Kevin Mani, Uppsala, Sweden |
17:40 - 17:45
Audience participation & discussion
17:45 - 17:55
Long-term outcomes of embolisation of type I endoleaks post EVAR
| Speaker: | Robert Morgan, London, United Kingdom |
17:55 - 18:00
Audience participation & discussion